Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

RX

5887 posts
  • This content is machine translated T helper 1 cells

Differentiation and activation of Th1 cells – a multi-omics approach

T cells are an important part of our immune system. T helper (Th) cells support and coordinate central functions of the adaptive immune response and thus contribute significantly to the...…
CME-Test
View Post
  • 4 min
  • This content is machine translated Cannabis for schizophrenia

CBD pre-treatment could exacerbate side effects

A significant proportion of people with schizophrenia use cannabis, with around one in five meeting the criteria for a comorbid cannabis use disorder, for which there are still limited effective...…
View Post
  • 11 min
  • This content is machine translated Type 2 diabetes: cardiovascular risk reduction is realistic

Modern active ingredients and lifestyle – every step counts

Although diabetics have an increased risk of developing cardiovascular diseases such as myocardial infarction, heart failure or stroke, scientific data suggests that protective effects can be achieved through the best...…
View Post
  • 7 min
  • This content is machine translated Case study

8-year-old girl with Pätau syndrome aka trisomy 13

The median survival time for live-born children with complete trisomy 13 without medical intervention is 7-10 days. Over 90% of affected newborns die in the first year of life. Risk...…
View Post
  • 4 min
  • This content is machine translated Lichen sclerosus

Interim analysis of a new register

So far, 60 patients1 with lichen sclerosus were included in the registry launched in Germany. The mean age of the included patients is 54 years 2. An interim assessment shows...…
View Post
  • 8 min
  • This content is machine translated Urothelial carcinoma

Immune and targeted therapy options: Evidence situation 2025/2026

The treatment of urothelial carcinoma has developed significantly in recent years. Modern immunotherapies, antibody-drug conjugates (ADCs) and targeted substances complement conventional chemotherapies and increasingly enable individualized treatment strategies. New data...…
View Post
  • 5 min
  • This content is machine translated SGLT2 inhibitors for type 2 diabetes and CKD

Prediction model beats albuminuria threshold

SGLT2 inhibitors also significantly reduce the risk of kidney disease progression in patients with type 2 diabetes and preserved kidney function, whereby the relative benefit is independent of albuminuria status....…
View Post
  • 4 min
  • This content is machine translated Risk of psychosis

Modulate cortical excitatory activity with diazepam

Individuals at clinical high risk for psych osis (CHRp) have an estimated 27% chance of developing a psychotic disorder within three years, but there are currently no established preventive pharmacological...…
View Post
  • 6 min
  • This content is machine translated MASLD/MASH: lifestyle, pharmacotherapy, bariatric procedures

Addressing metabolic drivers and counteracting fibrosis

Steatotic liver diseases that are not associated with alcohol consumption are now referred to as metabolic steatotic liver disease (MASLD) or metabolic dysfunction-associated steatohepatitis (MASH). There is now no need...…
View Post
  • 9 min
  • This content is machine translated Experiences from the EFFORT studies

Solutions to the malnutrition dilemma

The term malnutrition encompasses more than just insufficient food intake; it is an independent clinical picture with clearly defined effects on complication rates, functionality and mortality, which can be influenced...…
CME-Test
View Post
  • 6 min
  • This content is machine translated Chronic urticaria: new treatment alternatives in sight

If antihistamines are not sufficient and IgE levels are low

Chronic urticaria often leads to a high level of suffering, but new treatment options are on the way – a lot has happened since the publication of the current S3...…

Posts pagination

Previous 1 … 4 5 6 7 8 … 536 Next
Top CME content
  • 1
    Current State of Knowledge and New Therapeutic Approaches
  • 2
    Why is it so hard to lose weight?
  • 3
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 4
    Algorithms, avatars and the unburdened mind
  • 5
    Communication as the key to therapy adherence

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.